| Standard Chemical & Pharmaceutical Co. Ltd. - Taiwan | ||
| 1st Quarter ended March 31: | ||
| Figures in New Taiwan dollars. | ||
| 2025 | 2024 | |
| Revenue | NT$1,640,034,000 | NT$1,613,535,000 |
| Pretax Profit | NT$349,368,000 | NT$428,284,000 |
| Net Profit | NT$194,671,000 | NT$252,704,000 |
| Earnings Per Share | ||
| Basic | 1.09 | 1.41 |
| Diluted | 1.09 | 1.41 |
| Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. |
(END) Dow Jones Newswires
May 12, 2025 01:23 ET (05:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.